Itay & Beyond

Patient-derived lab grown brain tissue on a chip, to develop novel treatments for neurology and psyc

Health Tech & Life Sciences
Active
Pre-Funding Jerusalem, Israel Founded 2021
Website ↗ LinkedIn
Last updated 2026-06-18
Total raised
—
Stage
Pre-Funding
Founded
2021
Headcount
15
HQ
Jerusalem, Israel
Sector
Health Tech & Life Sciences

About

Itay & Beyond is a pioneering biotech startup revolutionizing neuropsychiatric drug discovery through its platform. The company is driven by the urgent need for more effective treatments in neuropsychiatry.

Q&A

What is Itay & Beyond's primary focus?
Itay & Beyond is a biotech startup focused on revolutionizing neuropsychiatric drug discovery using patient-derived lab-grown brain tissue on a chip to develop novel treatments for neurology and psychiatry.
When was Itay & Beyond founded?
Itay & Beyond was founded in January 2021.
How many employees does Itay & Beyond currently have?
Itay & Beyond has 11-50 employees.
What is Itay & Beyond's current funding stage?
Itay & Beyond is currently in the Pre-Funding stage.
Who is the Co-founder and CEO of Itay & Beyond?
Nissim Perets is the Co-founder and CEO of Itay & Beyond.
What is the product stage of Itay & Beyond?
The product stage of Itay & Beyond is R&D.
Where is Itay & Beyond headquartered?
Itay & Beyond is headquartered in Jerusalem, Israel.
What sectors does Itay & Beyond operate in?
Itay & Beyond operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Drugs Discovery & Development, and Digital Healthcare.

Team · 1

Nissim Perets
Founder · Co-founder and CEO
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & DevelopmentDigital Healthcare
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsBiotechnologyHealthcarePatients

Tags

drug-discoveryneuroscience
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)